Gunnar C Hansson Selected Research

Neoplasms (Cancer)

1/2020	Membrane mucins of the intestine at a glance.
1/2018	Highly Accurate Identification of Cystic Precursor Lesions of Pancreatic Cancer Through Targeted Mass Spectrometry: A Phase IIc Diagnostic Study.
2/2014	Proteomic mucin profiling for the identification of cystic precursors of pancreatic cancer.
2/2011	O-glycosylation of MUC1 mucin in prostate cancer and the effects of its expression on tumor growth in a prostate cancer xenograft model.
2/2009	Sensitive liquid chromatography-electrospray mass spectrometry allows for the analysis of the O-glycosylation of immunoprecipitated proteins from cells or tissues: application to MUC1 glycosylation in cancer.
1/2009	Molecular evolution of specific human antibody against MUC1 mucin results in improved recognition of the antigen on tumor cells.
2/2006	The ST6GalNAc-I sialyltransferase localizes throughout the Golgi and is responsible for the synthesis of the tumor-associated sialyl-Tn O-glycan in human breast cancer.
6/2005	Recombinant tumor-associated MUC1 glycoprotein impairs the differentiation and function of dendritic cells.
11/2004	Bcr (breakpoint cluster region) protein binds to PDZ-domains of scaffold protein PDZK1 and vesicle coat protein Mint3.
4/2004	MUC1 can interact with adenomatous polyposis coli in breast cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Gunnar C Hansson Research Topics

Disease

14	Cystic Fibrosis (Mucoviscidosis) 03/2023 - 11/2002
10	Inflammation (Inflammations) 01/2020 - 10/2004
10	Neoplasms (Cancer) 01/2020 - 04/2004
8	Colitis 11/2022 - 08/2010
7	Infections 01/2023 - 01/2002
4	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2024 - 11/2018
4	Breast Neoplasms (Breast Cancer) 01/2009 - 12/2003
3	Ulcerative Colitis 01/2015 - 04/2011
2	Inborn Genetic Diseases (Disease, Hereditary) 01/2023 - 01/2019
2	Lung Diseases (Lung Disease) 11/2022 - 01/2018
2	Chronic Obstructive Pulmonary Disease (COPD) 01/2018 - 01/2018
2	Carcinoma (Carcinomatosis) 02/2011 - 06/2003
2	Vaginitis 12/2009 - 10/2005
2	Carcinogenesis 02/2008 - 04/2004
2	Colonic Neoplasms (Colon Cancer) 03/2006 - 01/2004
1	Bacterial Infections (Bacterial Infection) 01/2023
1	Rupture 01/2022
1	Obesity 11/2020
1	Metabolic Diseases (Metabolic Disease) 11/2020
1	Enterocolitis 01/2019
1	Dysbiosis 01/2019
1	Stomach Ulcer (Gastric Ulcer) 11/2018
1	Adenocarcinoma 01/2018
1	Dehydration (Water Stress) 12/2014
1	Cystitis 11/2014
1	Reinfection 11/2014
1	Pancreatic Neoplasms (Pancreatic Cancer) 02/2014
1	Gastrointestinal Diseases (Functional Gastrointestinal Disorders) 01/2014
1	Periodontitis 05/2013
1	Ischemic Stroke 07/2011
1	Abscess 04/2011
1	Prostatic Neoplasms (Prostate Cancer) 02/2011
1	Diarrhea 01/2011
1	Multiple Myeloma 04/2010
1	Candidiasis (Moniliasis) 12/2009
1	Stomach Neoplasms (Stomach Cancer) 02/2009

Drug/Important Bio-Agent (IBA)

24	MucinsIBA 01/2024 - 01/2002
9	Polysaccharides (Glycans)IBA 01/2024 - 12/2003
8	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2004
5	Mucin-1 (CA 15-3 Antigen)IBA 02/2011 - 05/2003
4	Glycoproteins (Glycoprotein)IBA 01/2024 - 06/2005
4	Cystic Fibrosis Transmembrane Conductance Regulator (Protein, CFTR)IBA 01/2023 - 08/2014
4	Phenobarbital (Luminal)FDA Link 01/2023 - 02/2012
4	AntigensIBA 01/2018 - 02/2008
4	EpitopesIBA 12/2009 - 01/2002
3	CalciumIBA 01/2019 - 10/2015
3	Bicarbonates (Hydrogen Carbonate)IBA 01/2013 - 08/2010
3	Messenger RNA (mRNA)IBA 01/2013 - 01/2004
2	ProteomeIBA 03/2023 - 01/2018
2	Dextrans (Dextran)FDA Link 11/2022 - 01/2014
2	Cholinergic Agents (Cholinergics)IBA 01/2022 - 01/2018
2	Ion Channels (Ion Channel)IBA 08/2021 - 01/2013
2	AnionsIBA 08/2021 - 01/2019
2	Streptomycin (Streptomycin Sulfate)FDA Link 01/2019 - 01/2011
2	Biomarkers (Surrogate Marker)IBA 01/2018 - 01/2009
2	Carcinoembryonic AntigenIBA 01/2018 - 02/2014
2	OligosaccharidesIBA 12/2009 - 06/2005
2	N-Acetylneuraminic Acid (Sialic Acid)IBA 02/2006 - 01/2002
2	Phosphotransferases (Kinase)IBA 11/2004 - 04/2004
2	GlycosyltransferasesIBA 11/2002 - 04/2002
2	Blood Group Antigens (Blood Groups)IBA 04/2002 - 01/2002
1	Metalloproteases (Metalloproteinases)IBA 01/2023
1	Galectin 3 (LGALS3)IBA 01/2023
1	Tiopronin (Thiola)FDA Link 01/2023
1	sodium sulfate (sodium bisulfate)FDA LinkGeneric 11/2022
1	Type V Secretion SystemsIBA 01/2022
1	Sodium-Hydrogen ExchangersIBA 08/2021
1	Dietary Fiber FDA Link 11/2020
1	Blood Glucose (Blood Sugar)IBA 11/2020
1	Glucose (Dextrose)FDA LinkGeneric 11/2020
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2019
1	Acetylcholine (Acetylcholine Chloride)FDA Link 01/2018
1	Cholinergic Antagonists (Anticholinergics)IBA 01/2018
1	Pancreatic Elastase (Elastase)IBA 01/2018
1	AlginatesIBA 06/2017
1	CytokinesIBA 01/2015
1	Interleukin-6 (Interleukin 6)IBA 01/2015
1	Interleukin-10 (Interleukin 10)IBA 01/2015
1	Interleukin-17 (Interleukin 17)IBA 01/2015
1	Protein SIBA 12/2014
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 11/2014
1	Dexamethasone (Maxidex)FDA LinkGeneric 11/2014
1	InflammasomesIBA 03/2014
1	Peptides (Polypeptides)IBA 02/2014
1	Transcription Factors (Transcription Factor)IBA 01/2014
1	SodiumIBA 01/2014
1	Protein Disulfide-IsomerasesIBA 01/2014
1	Peptide Hydrolases (Proteases)FDA Link 05/2013
1	BestrophinsIBA 01/2013
1	ChloridesIBA 07/2012
1	varicella-zoster virus glycoprotein EIBA 07/2011
1	Interferon gamma ReceptorIBA 01/2011
1	Drinking WaterIBA 08/2010
1	Dextran SulfateIBA 08/2010
1	Carbonated WaterIBA 08/2010
1	Immunoglobulin A (IgA)IBA 04/2010

Therapy/Procedure

2	Therapeutics 01/2018 - 01/2009
2	Immunotherapy 02/2006 - 12/2003
1	Aftercare (After-Treatment) 01/2019
1	Immunomodulation 11/2014